GBI Research, Sep 2011, Pages: 97
’s disease, Parkinson’s disease, Epilepsy, Schizophrenia and Depression. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI
Frost & Sullivan, Dec 2008, Pages: 128
. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipelineanalysis. 1 EXECUTIVE SUMMARY
- Executive Summary
- - Introduction
2
GlobalData, Aug 2010, Pages: 76
Neurostimulation Devices - Global PipelineAnalysis, Opportunity Assessment and Market Forecasts to 2016 Neurostimulation Devices - Global PipelineAnalysis, Opportunity Assessment
Espicom Business Intelligence Ltd, Aug 2009, Pages: 84
to achieve sales in excess of ¥12 billion within our forecast period. The CNS pipeline also contains istradefylline, a potential treatment for Parkinson’s disease which Kyowa believes has blockbuster potential
Espicom Business Intelligence Ltd, Jan 2010, Pages: 82
now sells Schwarz-developed Neupro, a novel Parkinson’s disease treatment recently approved in the US and Europe. Sales of Neupro are forecast to reach EUR 257 million in 2012, and combined
GlobalData, Sep 2010, Pages: 121
.2.2 Mar 31, 2010: Genetic Defect In Schizophrenia Associates With Disruption In Brain Connection
12.2.3 Mar 31, 2010: New Preclinical Trial Gives Awareness Of Gene Mutation Causing Parkinson's Disease
12
GlobalData, Nov 2010, Pages: 140
: Genetic Defect In Schizophrenia Associates With Disruption In Brain Connection
11.3.4 Mar 31, 2010: New Preclinical Trial Gives Awareness Of Gene Mutation Causing Parkinson's Disease
12 Appendix
12
GlobalData, Sep 2010, Pages: 132
's Society
11.1.3 Apr 29, 2010: Surgery For Deep Brain Stimulation Benefits Patients With Parkinson's Disease: University Of Birmingham Study
11.1.4 Mar 04, 2010: Nuclear Physics Promises Earlier Detection
GlobalData, March 2011, Pages: 148
Awareness Of Gene Mutation Causing Parkinson's Disease
14 Appendix
14.1 Definitions of Markets Covered in the Report
14.1.1 Neurology Devices
14.2 Research Methodology
14.3 Secondary Research
14
GlobalData, March 2011, Pages: 155
With Disruption In Brain Connection
10.3.4 Mar 31, 2010: New Preclinical Trial Gives Awareness Of Gene Mutation Causing Parkinson's Disease
11 Appendix
11.1 Definitions of Markets Covered in the Report
11
GlobalData, March 2011, Pages: 152
and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team
GlobalData, Nov 2010, Pages: 143
Chips To Diagnose Heart Problems, Parkinson’s Disease
9.3.9 Mar 03, 2010: FDA Warning Letter To Genzyme Related To Allston Facility Will Have No Impact On Aldurazyme Sales, BioMarin Says
9.4 Product
GlobalData, Nov 2010, Pages: 169
.1.4 Apr 29, 2010: Surgery For Deep Brain Stimulation Benefits Patients With Parkinson's Disease: University Of Birmingham Study
12.1.5 Mar 23, 2010: Blood Flow In The Brain Can Now Be Measured In Real Time
GlobalData, March 2011, Pages: 185
Help Predict Alzheimer’s Disease Progression: Alzheimer's Society
12.1.4 Apr 29, 2010: Surgery For Deep Brain Stimulation Benefits Patients With Parkinson's Disease: University Of Birmingham Study
12
GlobalData, Nov 2010, Pages: 267
14, 2010: Neuroimaging Identifies Patients With REM Sleep Disturbances Who Will Suffer Parkinson's Disease: IDIBAPS
12.2.11 Aug 23, 2010: ASIR Algorithm Reduces Radiation Dose In CT Angiography
12
